Joint Commission of Taiwan

HST provides integrated services for healthcare institutions to achieve digital transformation, shaping a quality, safe, and efficient healthcare environment.
1.Gathering over a hundred excellent solutions in Taiwan
2.Providing success stories and demonstrating the benefits of clinical applications
3.Matchmaking : products, sites, and technologies.
4.Bridging gaps between the medical and technology industries: Facilitating communication between medical and technology industries through the Smart Healthcare Campaign, international forums, and workshops.
5.Trial sites: Implementing practical product applications in medical institutions to develop a series of smart healthcare solutions.
Join HST! Accelerate digital transformation of healthcare.

Joy Medical Devices Corporation

Joy Medical Devices (JMD), a highly R&D-oriented company established at Southern Taiwan Science Park in 2009, is committed to the development of dental and orthopedic biomaterials and related devices by the highest standards in medical device industry. JMD’s technology portfolio covers a series of innovative Ezechbone® products (regular and non-antibiotic antibacterial calcium-based cements and granular bone substitutes), minimally invasive highly porous granule and cement delivery system (jBranchTM), minimally invasive bone cavity creation systems, high strength-modulus ratio titanium alloy, in-situ re-adjustable craniofacial miniplate, smart dental implant, etc. JMD is an ISO 9001, ISO 13485, GMP, MOEA-Certified Biotech and New Pharmaceutical Company. Ezechbone®, developed by a NCKU/JMD joint research project, is an all-synthetic, all-inorganic, highly osteoconductive and fully resorbable calcium-based bone substitute materials. Ezechbone®Granule is a highly porous granular product characterized by its high resorption rate (totally resorbed and replaced by new bone in 3-6 months), while Ezechbone®Cement is featured by its unique non-dispersive behavior upon contact with blood/body fluid without need of any polymeric or other binder additives. The safety and efficacy of these medical devices were confirmed by a series of chemical/physical characterization and biocompatibility tests such as cytotoxicity, sub-chronic toxicity, intracutaneous reactivity, skin sensitization, ocular irritation, endotoxin test, hemolysis test, genotoxicity and implantation. Clinical indications of this series of Ca-based bone substitute materials include sinus lift, ridge augmentation, frontal bone augmentation and treatment for various types of fractures.

JunHong Biotechnology Co.,Ltd

一、Mangosteen Supplemental Drink
1.Award the health food certification for the effect of "regulating blood sugar"
2.Award the National Quality Biotechnology Medical Label
3.Exclusive whole fruit extraction technology, concentrated mangosteen extract phytochemicals in mangosteen, the whole bottle contains up to 730mg of xanthones. In addition, various plant polyphenols such as red pomegranate , acerola , tamarind are added to regulate physiological functions, promote metabolism, and maintain good health.

二、Mangosteen Simplelife Formula
1. Exclusive extraction technology of whole mangosteen fruit, perfect combination of Xanthon and polyphenols
2.Patented process‧more complete retention of xanthones and increased absorption of xanthones
3.Helps metabolism in the body, creates a bright appearance from the inside out, and maintains good skin quality
4.Adjustable physiological function, maintain beauty and keep young

三、Golden Smart
1.Award the National Quality Biotechnology Medical Label
2.Industry-academia cooperation with National Taiwan Normal University Taiwan and US patented formula
3.Boost metabolism and help you fall asleep

四、Synerdrink
1.Traditional Chinese medicine dual-use natural herbs, developed by applying modern nutritional medicine and advanced extraction process
2.The best guardian at the critical moment
3.100% all-natural herbs, promote fluid and quench thirst, regulate physiological functions, maintain health

JunZhi Biomedical Co., Ltd.

SAA cancer screening-related technologies and services have been available on the market for many years, but their accuracy is the most criticized. SAA TEST only takes three minutes to draw a tube of blood, and through the purification of exclusive nanoparticles, we can target and analyze the trace amount of SAA in the blood. The protein is analyzed by mass spectrometry, and the self-developed AI biological interpretation software is used to analyze the cancer risk. SAA TEST can already detect gastric cancer and colorectal cancer. In the actual clinical test, SAA has a accuracy of 77%.

Juqi Biotechnology Co., Ltd.

後補